Sugi Predict

Sugi Predict / Compounds / SCHEMBL671002

SCHEMBL671002

SCHEMBL671002

CC(=O)Oc1ccc(CC(N)C(=O)O)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC7A5 Q01650 4/20 0.61
▸ PTGS1 P23219 3/20 0.59
▸ ALPI P09923 1/20 0.59
▸ PKM P14618 1/20 0.59
▸ XIAP P98170 1/20 0.59
▸ PTPN1 P18031 1/20 0.59
▸ ITGB3 P05106 1/20 0.57
▸ ITGA2B P08514 1/20 0.57
▸ KMT2A Q03164 2/20 0.55
▸ POLB P06746 1/20 0.55
▸ ALOX15 P16050 3/20 0.51
▸ HIF1A Q16665 3/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ TDP1 Q9NUW8 2/20 0.51
▸ USP2 O75604 1/20 0.51
▸ EGFR P00533 1/20 0.51
▸ LCK P06239 1/20 0.51
▸ FYN P06241 1/20 0.51
▸ ADORA3 P0DMS8 1/20 0.51
▸ HTR2A P28223 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22645606 1.00 SLC7A5 (0.61) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL450849 1.00 SLC7A5 (0.61) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL451772 0.91 SLC7A5 (0.62) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL9980756 0.91 SLC7A5 (0.51) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL4581449 0.89 SLC7A5 (0.56) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL684102 0.88 LMNA (0.50) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL29543137 0.86 POLB (0.49) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL1639831 0.86 SLC7A5 (0.61) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL19115018 0.85 SLC7A5 (0.56) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL4629444 0.85 SLC7A5 (0.56) SLC7A5PTGS1ALPIPKMXIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4417221-A2 POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS Tyndall Formulation Services, LLC (US) 2024-08-21 — — EP claimed
CN-115135694-B Polymeric excipients for drug delivery applications 廷德尔配方服务有限责任公司 2024-03-15 — — CN claimed
EP-4087543-B1 POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS TYNDALL FORMULATION SERVICES LLC (US) 2024-03-06 — — EP claimed
US-11891482-B2 Polymer excipients for drug delivery applications Tyndall Formulation Services, LLC (US) 2024-02-06 — — US claimed
CN-115135694-A Polymeric excipients for drug delivery applications 廷德尔配方服务有限责任公司 2022-09-30 — — CN claimed
US-20220251296-A1 POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS Tyndall Formulation Services, LLC 2022-08-11 — — US claimed
US-11286344-B2 Polymer excipients for drug delivery applications Tyndall Formulation Services, LLC (US) 2022-03-29 — — US claimed
US-20210214496-A1 POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS Tyndall Formulation Services, LLC 2021-07-15 — — US claimed
EP-2036918-A1 PEPTIDE DERIVATIVE Vexon, Inc. (JP) 2009-03-18 — — EP claimed
US-20080009448-A1 Peptide Derivative VEXON, INC. (50%) (JP) 2008-01-10 — — US claimed
US-4960881-A REACTING AMINO ACID WITH ALPHA-CHLORINATED CARBONATE IN SOLVENT IN PRESENCE OF ACID SCAVENGER SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1990-10-02 — — US claimed
US-12358948-B2 Neurotensinergic agonists and methods of using same preventing or treating pain SOCPRA SCIENCES SANTÉ ET HUMAINES S.E.C. (CA) 2025-07-15 — — US disclosed
EP-4529542-A1 AMPHIPHILIC POLY(AMINO ACID) LINEAR BLOCK COPOLYMERS AND NANOPARTICLES THEREOF FOR DRUG DELIVERY APPLICATIONS Nanothera Biosciences, Inc. (US) 2025-04-02 — — EP disclosed
CN-119677795-A Amphiphilic poly (amino acid) linear block copolymers and nanoparticles thereof for drug delivery applications 纳诺瑟拉生物科学股份有限公司 2025-03-21 — — CN disclosed
EP-4417221-A2 POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS Tyndall Formulation Services, LLC (US) 2024-08-21 — — EP disclosed
US-4705864-A Aryl oxime derivatives of hydantoins THE STANDARD OIL COMPANY (US) 1987-11-10 — — US disclosed
US-4694044-A Adsorbent RESEARCH DEVELOPMENT CORP. OF JAPAN (JP) 1987-09-15 — — US disclosed
EP-0154343-A2 Adsorbent Research Development Corporation of Japan (JP) 1985-09-11 — — EP disclosed
US-4267344-A 3-PENTA/ALKOXY/BENZYL-; -XANTHYL-, -THIOXANTHYL-, OR -SELENOXANTHYLOXAZOLIDINE-2,5-DIONES PROTEINKEMISK INSTITUT. TILKNYTTET AKADEMIET FOR DE TEKNISKE VIDENSKABER (DK) 1981-05-12 — — US disclosed
US-3948863-A Solid, water-insoluble polypeptides having ionizable side chains AJINOMOTO CO., INC. (JA) 1976-04-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11286344-B2 Polymer excipients for drug delivery applications CLTB, ACTB, TNNC1 SLC7A5 20/4885PTGS1 3544/4885ALPI 1545/4885
US-20220251296-A1 POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS CLTB, ACTB, TNNC1 SLC7A5 20/4885PTGS1 3544/4885ALPI 1545/4885
US-11891482-B2 Polymer excipients for drug delivery applications CLTB, ACTB, TNNC1 SLC7A5 20/4885PTGS1 3544/4885ALPI 1545/4885
US-20210214496-A1 POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS CLTB, ACTB, TNNC1 SLC7A5 20/4885PTGS1 3544/4885ALPI 1545/4885
US-12358948-B2 Neurotensinergic agonists and methods of using same preventing or treating pain VIP, NTSR2, VIPR2 SLC7A5 2915/4885PTGS1 105/4885ALPI 192/4885
US-20080009448-A1 Peptide Derivative ARGLU1, NGLY1, NPR3 SLC7A5 221/4885PTGS1 1012/4885ALPI 4171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.